Clinical Trial Update: A Study to Investigate Arbaclofen ER Tablets for the Treatment of Spasticity in Patients With Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Arbaclofen ER tablets in the treatment of spasticity in patients with multiple sclerosis; the study is currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Arbaclofen ER (arbaclofen ER)

Snippet

Sponsor: RVL Pharmaceuticals, Inc. | Conditions: Spasticity | Phase 3 | Status: NOT_YET_RECRUITING